Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients
about
Metabolic syndrome after liver transplantation: preventable illness or common consequence?Diabetes and other endocrine-metabolic abnormalities in the long-term follow-up of pancreas transplantation.Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation.Novel views on new-onset diabetes after transplantation: development, prevention and treatment.New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.Guidelines for the treatment and management of new-onset diabetes after transplantation.Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature.Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature.Medical Management of Metabolic Complications of Liver Transplant Recipients.Neoral rescue therapy in transplant patients with intolerance to tacrolimus.Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment.
P2860
Q28728729-D35CA0FA-8D00-40A7-8FED-752F6127836CQ33802182-C81CA53F-6DE8-47D1-8D0E-05814B7AB567Q34371734-00C786A2-900A-4305-BA7A-F15B8571D5ABQ35221336-D3233A75-8A72-4E2D-BA83-72DB6E49B622Q35691924-ED237323-F2C7-45B9-B544-D1B78F8F23F2Q36015474-2C02DDDA-BACB-4A28-BDE9-2E5EA3112008Q36118632-6149173D-4E10-4255-BA3D-0DEF83D1FD37Q36399571-2645F162-C488-48E3-94C6-FC1AB2B7758EQ36622173-3FA8EBEE-AC3F-45C5-A579-2330CDBD3B8EQ36986132-A543FEC6-C19C-4661-9B4E-584B4A2AD21BQ37421526-3375C120-AEF6-4389-A961-1EBAE945FED9Q43993063-648D736C-B1D5-4048-8300-09719F446135Q46952935-70F270C3-917D-4F8B-9DEE-96021C391FB7Q50145783-4D239D12-5534-4860-87A5-B3054E2EFBA9
P2860
Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of tacrolimus-relate ...... in liver transplant recipients
@ast
Treatment of tacrolimus-relate ...... in liver transplant recipients
@en
Treatment of tacrolimus-relate ...... in liver transplant recipients
@nl
type
label
Treatment of tacrolimus-relate ...... in liver transplant recipients
@ast
Treatment of tacrolimus-relate ...... in liver transplant recipients
@en
Treatment of tacrolimus-relate ...... in liver transplant recipients
@nl
prefLabel
Treatment of tacrolimus-relate ...... in liver transplant recipients
@ast
Treatment of tacrolimus-relate ...... in liver transplant recipients
@en
Treatment of tacrolimus-relate ...... in liver transplant recipients
@nl
P2093
P356
P1476
Treatment of tacrolimus-relate ...... in liver transplant recipients
@en
P2093
C M Miller
L K Schluger
M E Schwartz
P A Sheiner
T M Fishbein
P2888
P356
10.1007/S001470050012
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1031359264